GRM1; GRM5; GABBR1; GRM3; GRM8; GRM4; GRM2; | |
FFAR1; FFAR4; ADORA3; | |
TSHR; | |
TDP1; BLM; GLA; FAAH; RECQL; TERT; TK1; HPGD; HSD17B10; ALOX15; ALDH1A1; ALOX12; USP2; UGT1A1; PNP; APEX1; | |
PTPN1; | |
GAA; | |
GRIK2; GRIA4; GRIA2; GRIK3; GRIK5; GRIK1; | |
GABRR1; | |
TRPV1; | |
GRK6; IKBKB; CDK1; MAPK1; PIM1; | |
CA3; CA5B; CA5A; CA1; CA12; CA9; CA14; CA7; CA4; CA6; CA2; | |
PPARA; PPARG; PPARD; | |
NR1I2; | |
KDM4E; | |
ALOX5; PTGS1; MAOB; XDH; | |
MMP2; MMP9; MMP1; | |
TLR2; | |
HIF1A; NFKB1; TP53; | |
KMT2A; | |
FUT7; | |
SLC6A1; SLC6A11; SLC1A1; | |
LMNA; FABP5; FABP2; FABP4; MAPT; FABP3; HTT; THPO; RAB9A; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | GLA | Alpha-galactosidase A | P06280 | CHEMBL2524 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0023052; signaling | GO:0051966; regulation of synaptic transmission, glutamatergic | 8.734E-12 | 7.460E-09 | GRIK1, GRIK2, GRIK3, GRM1, GRM2, GRM3, GRM4, GRM5, GRM8 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 8.933E-12 | 7.460E-09 | CYP1A2, CYP2A6, CYP2C19, CYP2C9, CYP3A4, NR1I2 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 5.069E-10 | 2.299E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 5.430E-10 | 2.413E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 2.110E-09 | 7.787E-07 | GRIA2, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 7.175E-09 | 2.140E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 3.742E-08 | 1.006E-05 | GRIA2, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5, TRPV1 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.804E-07 | 5.654E-05 | CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C9, CYP3A4, NR1I2, PPARD, UGT1A1 |
BP | GO:0008152; metabolic process | GO:0019372; lipoxygenase pathway | 8.394E-07 | 1.325E-04 | ALOX12, ALOX15, ALOX5, HPGD |
BP | GO:0008283; cell proliferation | GO:1904707; positive regulation of vascular smooth muscle cell proliferation | 3.301E-06 | 4.278E-04 | HPGD, MMP2, MMP9, TERT |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 8.374E-03 | 2.357E-02 | GAA; GLA |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 6.976E-06 | 6.383E-05 | UGT1A1; CYP1A2; CYP1A1; CYP1B1; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 9.357E-07 | 1.317E-05 | CYP2A6; CYP1A2; XDH |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.375E-05 | 2.808E-04 | MAOB; CYP1A2; CYP1A1; CYP1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 4.014E-07 | 6.382E-06 | CYP2C9; ALOX5; ALOX15; ALOX12; CYP2C19; PTGS1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.008E-07 | 3.675E-06 | CYP2C9; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.937E-08 | 5.907E-07 | CYP2C9; CYP2A6; UGT1A1; CYP1A2; ALDH1A1; CYP1A1; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.271E-22 | 2.327E-20 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.400E-08 | 9.619E-07 | CYP2C9; CYP2A6; UGT1A1; CYP1A2; CYP1A1; CYP1B1; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.957E-08 | 7.731E-07 | CYP2C9; CYP2A6; MAOB; UGT1A1; CYP1A2; CYP3A4; CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3 |
A00-B99: Certain infectious and parasitic diseases | Adult varicella zoster virus infection | B02 | TK1 |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5; RAB9A |
A00-B99: Certain infectious and parasitic diseases | Postherpetic neuralgia | B02.2, G44.847, G53.0 | TRPV1 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; MAOB |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; TERT; CDK1 |
C00-D49: Neoplasms | Overactive bladder disorder | C67, N32.81 | TRPV1; TRPV1 |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53 |